About the Company and History

India Glycols Limited (IGL) is a leading Indian chemical company specializing in bio-based chemicals, natural gums, industrial gases, spirits, and nutraceuticals. Established in 1983 and headquartered in Noida, India, IGL has built a strong presence in both domestic and global markets with a commitment to sustainable and eco-friendly chemical solutions.

Milestones and Timelines

• 1983: Incorporated as UP Glycols Limited.

• 1986: Renamed to India Glycols Limited.

• 1990s: Expanded into ethoxylates, glycol ethers, and acetates.

• 2000s: Entered the natural gums, potable spirits, and industrial gases segments.

• 2010s: Ventured into nutraceuticals and herbal extracts.

• Recent Years: Focused on sustainability and innovation, expanding bio-based chemical solutions.

Key Metrics (as of 2024)

• Market Capitalization: ₹3,895 crore.

• Share Price: ₹1,256.35 (NSE); ₹1,258.15 (BSE).

• P/E Ratio: 15.44x.

• P/B Ratio: 1.37x.

• Return on Equity (ROE): 9.19%.

• Operating Margin: 31.4% (up from 25.0% in FY23).

• Net Margin: 13.0% (up from 10.5% in FY23).

• Dividend Yield: 0.64%.

• Earnings Per Share (EPS): ₹49.01.

• Debt-to-Equity Ratio: 0.4x (moderate leverage).

Products and Segments

IGL operates through multiple key business segments:

1. Bio-based Specialities and Performance Chemicals: Ethylene glycols, ethoxylates, glycol ethers, acetates, and performance chemicals.

2. Potable Spirits: Extra neutral alcohols, rectified spirits, and Indian-made foreign liquor (IMFL), including whisky, rum, brandy, vodka, and gin.

3. Ennature Biopharma: Natural active pharmaceutical ingredients, nutraceuticals, botanical extracts, and spice extracts.

4. Industrial Gases: Liquid oxygen, argon, nitrogen, carbon dioxide, and ethylene oxide gas mixtures.

Revenue Mix & Financial Performance

• Total Revenue (FY24): ₹3,319.70 crore (Consolidated basis).

• Net Profit (FY24): ₹172.99 crore.

• Segment-Wise Revenue Contribution:

  • Bio-based Chemicals: 50%+

  • Potable Spirits: ~30%

  • Nutraceuticals and Herbal Extracts: 10%

  • Industrial Gases: ~10%

• Geographical Revenue Distribution:

  • Domestic Market: 75%

  • Export Market: 25%

• EBITDA Margin: 5.02%.

Market Share & Industry Trends

• Industry Positioning: IGL is a pioneer in bio-based chemical manufacturing, competing with major players like Deepak Nitrate, Navin Flourine and Tata Chemicals.

• Emerging Trends:

  • Increasing demand for bio-based and sustainable chemicals.

  • Government push for ethanol blending and green initiatives.

  • Rising interest in nutraceuticals and herbal extracts.

Order Book & Growth Outlook

• Expansion into new R&D capabilities and product innovations.

• Potential partnerships in biofuels and sustainable chemicals.

• Increased focus on export markets to drive future revenue growth.

Peer Comparison

Shareholding Pattern (as of December 31, 2024)

SWOT Analysis

Strengths

• Diversified product portfolio with bio-based specialty chemicals.

• Strong promoter holding (61.01%).

• Established export presence.

Weaknesses

• Relatively lower EBITDA margin of 5.02%.

• Dependence on crude oil price fluctuations for raw material costs.

Opportunities

• Growing demand for bio-based chemicals in personal care and pharma.

• Expansion into nutraceuticals and herbal extracts.

• Government incentives for green chemistry initiatives.

Threats

• Intense competition from global and domestic players.

• Supply chain disruptions and raw material price volatility.

• Regulatory changes affecting chemical manufacturing.

Bottom Line & Investment Perspective

India Glycols Limited has positioned itself as a key player in bio-based chemicals and specialty ingredients, with a strong focus on sustainability. Despite facing margin pressures, its diversified revenue streams and strategic expansion into high-growth sectors provide significant upside potential. Investors looking for exposure to eco-friendly and sustainable chemical manufacturing may find IGL an attractive long-term bet, provided they account for industry cyclicality and margin constraints.